Literature DB >> 10522890

Mechanisms and clinical features of posterior border-zone infarcts.

J R Belden1, L R Caplan, M S Pessin, E Kwan.   

Abstract

BACKGROUND: Previous studies link posterior border-zone cerebral infarcts between the middle cerebral artery (MCA) and the posterior cerebral artery (PCA) to hemodynamic causes, not embolism.
OBJECTIVE: To study the cause of these infarcts.
METHODS: We studied 21 patients (unilateral = 18, bilateral = 3) with acute, symptomatic posterior border-zone infarcts shown on CT or MRI to clarify stroke mechanisms. Patients were identified by review of CT and MRI logs and medical records during a 35-month period. An embolic mechanism was assigned when a source of embolism from either the heart, aorta, or parent large artery was present in the absence of intrinsic MCA or PCA disease. A hemodynamic mechanism was assigned when systemic hypotension was present.
RESULTS: Among patients with unilateral lesions, 10 were embolic (7 cardiac, 3 carotid), 7 were unknown, and one patient had vasospasm from a ruptured aneurysm. Visual field abnormalities predominated over motor, sensory, and language abnormalities. All patients with bilateral posterior border-zone lesions had perioperative hypotension. Prolonged lethargy, bilateral limb weakness, and cortical blindness were common.
CONCLUSIONS: Embolism, either cardiac or from the parent carotid artery, is the predominant stroke mechanism in unilateral posterior border-zone infarcts, not distal field perfusion failure. Bilateral posterior border-zone infarcts have a distinctive clinical presentation and are caused by systemic hypotension. Variability of irrigation of the major arteries, passage of emboli to border-zone areas, and decreased clearance of emboli in these areas explain the findings in the patients with unilateral lesions.

Entities:  

Mesh:

Year:  1999        PMID: 10522890     DOI: 10.1212/wnl.53.6.1312

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

Review 1.  Distribution territories and causative mechanisms of ischemic stroke.

Authors:  A Rovira; E Grivé; A Rovira; J Alvarez-Sabin
Journal:  Eur Radiol       Date:  2005-01-19       Impact factor: 5.315

2.  Stroke in sickle cell disease in Africa: case report.

Authors:  J Makani
Journal:  East Afr Med J       Date:  2004-12

3.  [A cerebral watershed infarction after general anaesthesia in a patient with increased anti-cardiolipin antibody level].

Authors:  S J C Verbrugge; M Klimek; J Klein
Journal:  Anaesthesist       Date:  2004-04       Impact factor: 1.041

4.  Infratentorial strokes for posterior circulation folks: clinical correlations for current translational therapeutics.

Authors:  Tim Lekic; Paul R Krafft; Jacqueline S Coats; Andre Obenaus; Jiping Tang; John H Zhang
Journal:  Transl Stroke Res       Date:  2011-06-01       Impact factor: 6.829

5.  Pattern of collaterals, type of infarcts, and haemodynamic impairment in carotid artery occlusion.

Authors:  H Yamauchi; T Kudoh; K Sugimoto; M Takahashi; Y Kishibe; H Okazawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

6.  Association of Low Blood Pressure, Low Bispectral Index and Low Minimum Alveolar Concentration of Anaesthetic during Surgery with Postoperative 30-day Mortality: A Systemic Review and Meta-Analysis.

Authors:  Tak Kyu Oh; Young Mi Park; In Ae Song; Sang Hon Park
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-12-01

7.  Posterior Reversible Encephalopathy Syndrome Resolving Within 48 Hours in a Normotensive Patient Who Underwent Thoracic Spine Surgery.

Authors:  Kunal Vakharia; Ioannis Siasios; Vassilios G Dimopoulos; John Pollina
Journal:  J Clin Med Res       Date:  2016-01-26

Review 8.  Mechanisms and Neuroimaging Patterns of Hypereosinophilia-Related Ischemic Stroke: A Narrative Review through Three Cases.

Authors:  Maria Cristina Cioclu; Francesco Cavallieri; Manuela Napoli; Claudio Moratti; Rosario Pascarella; Franco Valzania; Marialuisa Zedde
Journal:  J Clin Med       Date:  2022-09-23       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.